Nagaland: COVID-19 vaccine dry run held at 3 sites in Dimapur

The dry run for COVID-19 vaccination was conducted at District Hospital Dimapur; Community Health Centre, Medziphema; and Urban Public Health Centre, Duncan Bosti Dimapur on January 2. (Photo: @pangnyu/ Twitter)

The dry run for COVID-19 vaccination was conducted at District Hospital Dimapur; Community Health Centre, Medziphema; and Urban Public Health Centre, Duncan Bosti Dimapur on January 2. (Photo: @pangnyu/ Twitter)

Dimapur, January 3 (MExN): Nagaland joined the rest of the country by successfully conducting a dry run for COVID-19 vaccination at 3 sites in Dimapur on January 2.

The dry run for the vaccination was conducted at the District Hospital Dimapur; Community Health Centre, Medziphema; and Urban Public Health Centre, Duncan Bosti DImapur. 

The State’s DIPR reported that the session sites were set up as per the guidelines given by the Union Ministry of Health and Family Welfare.

Each site had 3 rooms - waiting, vaccination and observation rooms while each vaccination team consisted of 5 members - a vaccinator officer and 4 others officers for verification, mobilising vaccination,  portal uploading and observation. 

During the dry run, 25 beneficiaries were selected in each session site for conducting the proposed activity, the report informed.

The dry run was supervised by officials from State and District level comprising of Mission Director NHM, Deputy Commissioner Dimapur, State Immunisation officer, other administrative officers, CMO team and officials from medical and other departments.

The objective of the dry run for COVID-19 vaccination is to assess operational feasibility in the use of Co-WIN application in field environment and also for assessing the preparedness for the vaccination drive as and when it becomes available, the report said. 

As and when the vaccine is rolled out, the first phase will cover health care workers, 2nd phase will cover the frontline workers, while the 3rd phase will cover population above 50 years of age and persons with co-morbidities including children, it added.